Johnson & Johnson (JNJ) EPS & PE Ratio History

Current and historical earning per share (EPS) and price to earnings (PE) ratio for Johnson & Johnson (JNJ) over the last 10 years. The current PE ratio for Johnson & Johnson as of November 16, 2017 is 19.45.

Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $373.077B $71.890B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.